Examples of 'placebo groups' in a sentence
Meaning of "placebo groups"
Placebo groups are used in medical or scientific research studies as a control group to compare the effects of an experimental treatment with those of a non-active substance or intervention. Placebos are designed to resemble the active treatment but do not contain the active ingredient or therapeutic property being studied. By comparing results between the experimental group and the placebo group, researchers can evaluate the true effects of the treatment being tested
How to use "placebo groups" in a sentence
Basic
Advanced
placebo groups
The control and placebo groups showed no change.
Convulsions were common in the placebo groups.
The treatment and placebo groups were given the same instructions.
Demographics were comparable between the sunitinib and placebo groups.
The placebo groups show no significant changes in performance and the psychical condition.
Between active and placebo groups.
The tamoxifen and placebo groups were well balanced for baseline demographic and prognostic factors.
Hypersensitivity reactions were also very common in the placebo groups.
The difference between the GapC and the placebo groups was statistically significant.
The areas at risk are comparable between verum and placebo groups.
Researchers compare the active treatment and placebo groups to see how well a treatment works.
There was no mortality difference between the amiodarone and placebo groups.
Subjects in the treatment and placebo groups are matched for IQ.
Incidences of serious TEAEs were similar in the lixisenatide and placebo groups.
The CTLA4Ig and placebo groups were generally balanced with respect to baseline disease characteristics.
See also
The incidence of these AEs was also high in the placebo groups.
Therapeutic Cure for the placebo groups at EOT and TOC was 0 %.
There was no significant difference in risk between the supplement and placebo groups.
Studies that compared Botox treatment groups to placebo groups show that Botox is effective.
The clinical trial reported cases of amputations in both the canagliflozin and placebo groups.
Placebo groups of 3 and 2 subjects received 1 and 2 injections of saline respectively.
No differences were demonstrated between the treated and placebo groups in this study.
The placebo groups lost approximately 1 % of BMD over 24 months.
The same pattern was observed in both the barusiban and placebo groups.
Cardiovascular events were reported in both celecoxib and placebo groups in one study ( 149 participants ).
Kaplan-Meier analysis of time to augmentation showed no significant difference between pramipexole and placebo groups.
The median time on-treatment in the Eklira Genuair and placebo groups was 1.1 and 1 year, respectively.
The primary comparison was the difference in growth rates between montelukast sodium and placebo groups.
The median time on-treatment in the Bretaris Genuair and placebo groups was 1.1 and 1 year, respectively.
Results remained significant for all ultrasound endpoints between the probucol alone and placebo groups.
The nominal p-value from comparison between mAb1 and placebo groups will be provided.
Other study outcomes also did not differ between the progesterone and the placebo groups.
The baseline characteristics were similar for the neomycin and placebo groups ( Table 1, below ).
The incidence of pain did not differ between the clonidine and placebo groups.
VO2max at baseline was similar in the perhexiline and placebo groups ( Table 2 ).
The outcomes were similar to the groups taking Proscar and superior to the placebo groups.
The distribution of HBV genotypes at baseline was similar between the TDF and Placebo groups.
This reduction was similar in the MO-emulsion and the placebo groups.
In all experiments, a high level of infection was seen in all placebo groups.
Patients were evenly distributed between zoledronic acid - treated and placebo groups.
Patients were evenly distributed between zoledronic acid-treated and placebo groups.
In clinical trials, musculoskeletal pain was very common in both denosumab and placebo groups.
Treatment-emergent side effects were also similar between benzoate and placebo groups.
Infusion reactions decreased to 2 % following the second infusion in both rituximab and placebo groups.
The effect of other medical treatments remains modest, although significant compared to placebo groups.
The frequencies of adverse events were generally similar for the CTLA4Ig and placebo groups.
The primary analysis was a comparison of depression-free rates between the bupropion and placebo groups.
Drop-out rates were low in the trials, affecting similar proportions of treatment and placebo groups.
Patients were evenly distributed between Zometa-treated and placebo groups.
There was no difference in GSRS-IBS scores between gluten and placebo groups.
You'll also be interested in:
Examples of using Groups
Show more
Armed groups also stand accused of torture
The most significant groups are the following
The groups meet three times a year
Examples of using Placebo
Show more
The placebo that was used included lactose
Endocannabinoids are involved in placebo induced analgesia responses
Placebo was not effective in any of the patients
